516700622	516700622	CD	B-NP	O
|	|	NN	I-NP	O
MAPVH	MAPVH	NN	I-NP	O
|	|	NN	I-NP	O
23595985	23595985	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0400906	0400906	CD	B-NP	O
|	|	CC	I-NP	O
8/6/2006	8/6/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Labile	Labile	NNP	I-NP	O
Blood	Blood	NNP	I-NP	O
Pressure	Pressure	NNP	I-NP	O
,	,	,	O	O
Viral	Viral	NNP	B-NP	O
illness	illness	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/6/2006	8/6/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/23/2006	10/23/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
PETTINGILL	PETTINGILL	NNP	B-NP	O
,	,	,	O	O
WAYNE	WAYNE	NNP	B-NP	O
M	M	NNP	I-NP	O
011-31-75-9	011-31-75-9	CD	I-NP	O
And	And	NNP	I-NP	O
Ton	Ton	NNP	I-NP	O
Leah	Leah	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/12/06	9/12/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GUDIEL	GUDIEL	NNP	B-NP	O
,	,	,	O	O
BLAIR	BLAIR	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.S.	M.S.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
4pm	4pm	NN	B-NP	O
and	and	CC	I-NP	O
9pm	9pm	NN	I-NP	B-DNA
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	I-DNA
ACID	ACID	NN	I-NP	I-DNA
81	81	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
LIPITOR	LIPITOR	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
80	80	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
CALTRATE	CALTRATE	NNP	I-NP	I-DNA
600	600	CD	I-NP	I-DNA
+	+	SYM	I-NP	I-DNA
D	D	NN	I-NP	I-DNA
-LRB-	-LRB-	SYM	O	I-DNA
CALCIUM	CALCIUM	NN	B-NP	I-DNA
CARBONATE	CARBONATE	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	B-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
PLAVIX	PLAVIX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
75	75	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LASIX	LASIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
18	18	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/24	10/24	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
give	give	VB	B-VP	O
before	before	IN	B-PP	O
dinner	dinner	NN	B-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
72	72	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
IMDUR	IMDUR	NNP	I-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
LABETALOL	LABETALOL	NN	I-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
400	400	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
130	130	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

LEVOXYL	LEVOXYL	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
112	112	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
8am	8am	CD	B-NP	O
NTG	NTG	NN	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	:	O	O
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
X	X	NN	I-NP	O
3	3	CD	I-NP	O
doses	dose	VBZ	B-VP	O
PRILOSEC	PRILOSEC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
OXYCODONE	OXYCODONE	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q10am	Q10am	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/25/06	7/25/06	CD	B-NP	O
by	by	IN	B-PP	O
BORROLLI	BORROLLI	NN	B-NP	O
,	,	,	O	O
JARVIS	JARVIS	NN	B-NP	O
D	D	NN	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
OXYCODONE	OXYCODONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
956464856	956464856	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Codeine	Codeine	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
NAUSEA	NAUSEA	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NN	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
EVERY	EVERY	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DAY	DAY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/12/06	9/12/06	CD	B-NP	O
by	by	IN	B-PP	O
CABAG	CABAG	NN	B-NP	B-protein
,	,	,	O	O
STACY	STACY	NN	B-NP	O
,	,	,	O	O
PA-C	PA-C	NN	B-NP	B-protein
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
984756390	984756390	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitor	monitor	VB	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/25/06	7/25/06	CD	B-NP	O
by	by	IN	B-PP	O
CAPEK	CAPEK	NN	B-NP	B-protein
,	,	,	O	O
BRANT	BRANT	NN	B-NP	B-protein
,	,	,	O	O
PA-C	PA-C	NN	B-NP	B-protein
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
021106169	021106169	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitor	monitor	NN	B-NP	O
VALSARTAN	VALSARTAN	NNP	B-NP	O
160	160	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/12/06	9/12/06	CD	B-NP	O
by	by	IN	B-PP	O
RICKENBAUGH	RICKENBAUGH	NN	B-NP	O
,	,	,	O	O
SAMMIE	SAMMIE	NN	B-NP	O
,	,	,	O	O
PA-C	PA-C	NN	B-NP	B-protein
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
984756390	984756390	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
VALSARTAN	VALSARTAN	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitor	monitor	VB	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/25/06	7/25/06	CD	B-NP	O
by	by	IN	B-PP	O
MINNIS	MINNIS	NN	B-NP	O
,	,	,	O	O
BRADY	BRADY	NN	B-NP	B-protein
,	,	,	O	O
PA-C	PA-C	NN	B-NP	B-protein
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
021106169	021106169	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
VALSARTAN	VALSARTAN	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitor	monitor	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	I-NP	O
NAS	NAS	NN	I-NP	B-protein
/	/	SYM	I-NP	O
Carbohydrate	Carbohydrate	NN	I-NP	O
Controlled	Control	VBN	B-VP	O
/	/	SYM	B-NP	B-protein
Low	Low	NN	I-NP	I-protein
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FDI	FDI	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ACTIVITY	ACTIVITY	NNP	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
for	for	IN	B-PP	O
apt	apt	JJ	B-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
AMOXICILLIN	AMOXICILLIN	NN	B-NP	B-protein
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
,	,	,	O	O
NUTS	NUTS	NNS	B-NP	B-protein
AND	AND	CC	I-NP	O
STRAWBERRIES	STRAWBERRIES	NNS	I-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Hypertensive	Hypertensive	JJ	B-NP	O
urgency	urgency	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Labile	Labile	NNP	I-NP	O
Blood	Blood	NNP	I-NP	O
Pressure	Pressure	NNP	I-NP	O
,	,	,	O	O
Viral	Viral	NNP	B-NP	O
illness	illness	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
S/P	S/P	NNP	I-NP	O
R	R	NNP	I-NP	O
CEA	CEA	NNP	I-NP	O
ON	ON	NNP	I-NP	O
10/2	10/2	CD	I-NP	O
DM	DM	NN	I-NP	O
SINCE	SINCE	NN	I-NP	O
1980	1980	CD	I-NP	O
S.P	S.P	NN	I-NP	O
L	L	NN	I-NP	O
THR	THR	NN	I-NP	O
S/P	S/P	NN	I-NP	O
L	L	NN	I-NP	O
TIBIAL	TIBIAL	NN	I-NP	O
FRACTURE	FRACTURE	NN	I-NP	O
HTN	HTN	NN	I-NP	O
S/P	S/P	NN	I-NP	O
PTCA	PTCA	NN	I-NP	O
3/3	3/3	CD	I-NP	O
RCA	RCA	NN	I-NP	O
diastolic	diastolic	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CRI	CRI	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
osteoporosis	osteoporosis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
osteoporosis	osteoporosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hypothyroidism	Hypothyroidism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PVD	PVD	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
L	L	NN	I-NP	O
fifth	fifth	JJ	I-NP	O
toe	toe	NN	I-NP	O
amputation	amputation	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
stents	stent	NNS	I-NP	O
X3	X3	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
stent	stent	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Head	Head	NNP	I-NP	O
CT.	CT.	NNP	I-NP	O
.	.	.	O	O

Portable	Portable	JJ	B-NP	B-protein
CXR	CXR	NN	I-NP	I-protein
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
Ultrasound	Ultrasound	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Lightheadness	Lightheadness	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
--	--	:	O	O
DDX	DDX	NN	B-NP	O
:	:	:	O	O
Hypertensive	Hypertensive	JJ	B-NP	O
Urgency	Urgency	NN	I-NP	O
--	--	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
77	77	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
three	three	CD	B-NP	O
stents	stent	NNS	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
and	and	CC	I-NP	O
CKD	CKD	NN	I-NP	B-protein
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
office	office	NN	B-NP	O
with	with	IN	B-PP	O
malaise	malaise	NN	B-NP	O
,	,	,	I-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
first	first	RB	B-VP	O
developed	develop	VBN	I-VP	O
on	on	IN	B-PP	O
Thursday	Thursday	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
checked	check	VBN	I-VP	O
her	her	PRP$	B-NP	O
BS	BS	NN	I-NP	O
and	and	CC	I-NP	O
BP	BP	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
300	300	CD	B-NP	O
and	and	CC	I-NP	O
150	150	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
resolved	resolve	VBD	B-VP	O
but	but	CC	I-VP	O
returned	return	VBD	I-VP	O
on	on	IN	B-PP	O
Sunday	Sunday	NNP	B-NP	O
PTA	PTA	NNP	I-NP	O
and	and	CC	O	O
persisted	persist	VBD	B-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
so	so	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
PCPs	PCP	NNS	I-NP	B-protein
office	office	NN	I-NP	I-protein
her	her	PRP$	B-NP	I-protein
BP	BP	NN	I-NP	I-protein
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
212	212	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
route	route	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PCP	PCP	NN	I-NP	O
office	office	NN	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
fleeting	fleeting	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
``	``	``	I-NP	O
cramping	cramping	NN	I-NP	O
''	''	''	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
unlike	unlike	IN	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
angina	angina	NN	I-NP	O
or	or	CC	I-NP	O
MI	MI	NN	I-NP	B-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

--	--	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
labetolol	labetolol	NN	B-NP	O
10mg	10mg	NN	I-NP	O
IV	IV	CD	I-NP	O
X2	X2	NN	I-NP	O
,	,	,	O	O
labetolol	labetolol	NN	B-NP	O
400mg	400mg	NN	I-NP	O
po	po	NN	I-NP	O
X1	X1	NN	I-NP	O
,	,	,	O	O
nitropaste	nitropaste	NN	B-NP	O
3	3	CD	I-NP	O
''	''	''	O	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
BP	BP	NN	I-NP	I-protein
remained	remain	VBD	B-VP	O
above	above	IN	B-PP	O
200	200	CD	B-NP	O
despite	despite	IN	B-PP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
hydralazine	hydralazine	NN	B-NP	O
10mg	10mg	NN	I-NP	O
IV	IV	CD	I-NP	O
X1	X1	NN	I-NP	B-DNA
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
dropping	drop	VBG	B-VP	O
her	her	PRP$	B-NP	O
BP	BP	NN	I-NP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
.	.	.	O	O

--	--	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
see	see	VB	B-VP	O
list	list	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
Meds	Med	NNS	B-NP	O
at	at	IN	B-PP	O
Home	Home	NNP	B-NP	O
:	:	:	O	O
Asa	Asa	NNP	B-NP	O
81	81	CD	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
Valsartan	Valsartan	NNP	B-NP	O
160	160	CD	I-NP	O
,	,	,	O	O
labetolol	labetolol	NN	B-NP	O
400	400	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
Spironolactone	Spironolactone	NN	B-NP	O
12.5	12.5	CD	I-NP	O
QOD	QOD	NN	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
80	80	CD	I-NP	O
,	,	,	O	O
Levoxyl	Levoxyl	NNP	B-NP	O
112	112	CD	I-NP	O
,	,	,	O	O
Oxycodone	Oxycodone	NN	B-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
lantus	lantus	NN	B-NP	O
70	70	CD	B-NP	O
qhs	qh	NNS	I-NP	O
,	,	,	O	O
Humalog	Humalog	NN	B-NP	O
18q	18q	NN	I-NP	O
breakfast	breakfast	NN	I-NP	O
,	,	,	O	O
20q	20q	NN	B-NP	O
supper	supper	NN	I-NP	O
,	,	,	O	O
colace	colace	NN	B-NP	O
100	100	CD	I-NP	O
tid	tid	NN	I-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
NTG	NTG	NN	B-NP	O
SL	SL	NN	I-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
ALL	ALL	NN	B-NP	O
:	:	:	O	O
amox-diarrhea	amox-diarrhea	NN	B-NP	O
,	,	,	O	O
codeine-nausea	codeine-nausea	NN	B-NP	O
,	,	,	O	O
Lisinopril-cough	Lisinopril-cough	NNP	B-NP	O
,	,	,	O	O
Nuts	Nut	NNPS	B-NP	O
&	&	CC	I-NP	O
strawberries	strawberry	NNS	I-NP	O
--	--	:	O	O
anaphylaxis	anaphylaxis	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
PE	PE	NN	B-NP	O
on	on	IN	B-PP	O
Admit	Admit	NNP	B-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	B-protein
96.3	96.3	CD	I-NP	I-protein
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
84	84	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
128/64	128/64	CD	I-NP	I-DNA
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
,	,	,	O	O
O2	O2	NN	B-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
pale	pale	JJ	B-NP	O
HEENT	HEENT	NNP	I-NP	O
:	:	:	O	O
PERRLA	PERRLA	NN	B-NP	O
,	,	,	O	O
anicteric	anicteric	JJ	B-NP	O
NECK	NECK	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
JVD	JVD	NN	I-NP	B-protein
or	or	CC	I-NP	O
LAD	LAD	NN	I-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
+	+	SYM	B-NP	O
SEM	SEM	NN	I-NP	O
at	at	IN	B-PP	O
RUSB	RUSB	NNP	B-NP	O
Abd	Abd	NNP	I-NP	O
:	:	:	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
NT	NT	NNP	B-NP	O
,	,	,	O	O
ND	ND	NNP	B-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
c/c/e	c/c/e	NN	I-NP	O
Neuro	Neuro	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
--	--	:	O	O
CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
stable	stable	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
ECHO	ECHO	NN	I-NP	O
1/28	1/28	CD	B-NP	O
EF	EF	NN	I-NP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
RWMA	RWMA	NN	I-NP	O
Cath	Cath	NN	I-NP	O
2/25	2/25	CD	I-NP	O
pLAD	pLAD	NN	I-NP	O
discrete	discrete	JJ	I-NP	O
45	45	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
mid	mid	JJ	B-NP	O
LCx	LCx	NNP	I-NP	O
discrete	discrete	NN	I-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
pRCA	pRCA	NN	B-NP	O
discrete	discrete	JJ	I-NP	O
35	35	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
Head	Head	NN	I-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
intracranial	intracranial	JJ	I-NP	O
process	process	NN	I-NP	O
--	--	:	O	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
urgency	urgency	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
high	high	JJ	I-NP	O
BP	BP	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
indication	indication	NN	I-NP	O
of	of	IN	B-PP	O
med	me	VBN	B-NP	O
non-compliance	non-compliance	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
reports	report	VBZ	B-VP	O
labile	labile	JJ	B-NP	O
BPs	BP	NNS	I-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
problem	problem	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
BP	BP	NN	I-NP	I-protein
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
arrived	arrive	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
resumed	resume	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Labetolol	Labetolol	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
discussion	discussion	NN	B-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
her	her	PRP$	B-NP	O
labetolol	labetolol	NN	I-NP	O
dose	dose	NN	I-NP	O
but	but	CC	O	O
this	this	DT	B-NP	O
ended	end	VBD	B-VP	O
up	up	RP	B-PRT	O
not	not	RB	O	O
being	be	VBG	B-VP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
fact	fact	NN	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
symptomatic	symptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BP	BP	NN	I-NP	O
of	of	IN	B-PP	O
120	120	CD	B-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
feeling	feeling	NN	B-NP	O
lightheaded	lightheade	VBN	B-VP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
her	her	PRP$	B-NP	O
hold	hold	NN	I-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
130	130	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
occasional	occasional	JJ	B-NP	O
ectopic	ectopic	JJ	I-NP	O
apical	apical	JJ	I-NP	O
heart	heart	NN	I-NP	O
beats	beat	NNS	I-NP	O
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
QRS	QRS	NNS	I-NP	O
complex	complex	JJ	B-NP	O
and	and	CC	I-NP	O
occasional	occasional	JJ	I-NP	O
slight	slight	JJ	I-NP	O
pauses	pause	NNS	I-NP	O
<	<	SYM	B-NP	O
2sec	2sec	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
major	major	JJ	I-NP	O
events	event	NNS	I-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
slow	slow	JJ	I-ADJP	O
around	around	IN	B-PP	O
50-55	50-55	CD	B-NP	O
much	much	JJ	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
did	do	VBD	B-VP	O
show	show	VB	I-VP	O
slight	slight	JJ	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
1mm	1mm	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
ST	ST	NN	I-NP	O
segment	segment	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
antero-lateral	antero-lateral	JJ	B-NP	O
leads	lead	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
CKMB	CKMB	NN	I-NP	B-protein
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
neg	neg	NN	B-NP	B-protein
troponins	troponin	NNS	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
had	have	VBD	I-VP	O
slight	slight	JJ	B-NP	O
demand	demand	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CKMB	CKMB	NN	I-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
troponins	troponin	NNS	I-NP	O
were	be	VBD	B-VP	O
always	always	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
s/s	s/	NNS	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
major	major	JJ	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
diabetic	diabetic	JJ	I-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
reports	report	VBZ	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
contrast	contrast	NN	B-NP	O
induced	induced	JJ	I-NP	O
nephropathy	nephropathy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
proteinuria	proteinuria	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
slighly	slighly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
usual	usual	JJ	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
3	3	CD	I-NP	O
+	+	SYM	B-NP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
but	but	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
to	to	TO	B-PP	O
1.6	1.6	CD	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
1.8-2	1.8-2	CD	I-NP	O
.2	.2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
kidneys	kidney	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
hydronephrosis	hydronephrosis	NN	I-NP	O
.	.	.	O	O

UPEP	UPEP	NN	B-NP	O
,	,	,	I-NP	O
SPEP	SPEP	NN	I-NP	B-protein
and	and	CC	I-NP	O
spot	spot	NN	I-NP	B-protein
urine/protein	urine/protein	NN	I-NP	I-protein
were	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
spot	spot	NN	I-NP	B-protein
urine	urine	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
222	222	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
proteinuria	proteinuria	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
problem	problem	NN	I-NP	O
.	.	.	O	O

UPEP/SPEP	UPEP/SPEP	NN	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
but	but	CC	O	O
suspicion	suspicion	NN	B-NP	O
for	for	IN	B-PP	O
malignancy	malignancy	NN	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
.	.	.	O	O

--	--	:	O	O
ENDO	ENDO	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
DM	DM	NN	B-NP	O
and	and	CC	O	O
takes	take	VBZ	B-VP	O
Lantus	Lantus	NNP	B-NP	O
and	and	CC	I-NP	O
Humolog	Humolog	NNP	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
missed	miss	VBD	B-VP	O
her	her	PRP$	B-NP	O
lantus	lantus	NN	I-NP	O
dose	dose	NN	I-NP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
am	am	NN	I-NP	O
BS	BS	NN	I-NP	O
was	be	VBD	B-VP	O
high	high	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
NPH	NPH	NN	B-NP	B-protein
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
HD	HD	NN	I-NP	B-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
and	and	CC	O	O
then	then	RB	O	O
she	she	PRP	B-NP	O
resumed	resume	VBD	B-VP	O
Lantus	Lantus	NNP	B-NP	O
that	that	IN	B-SBAR	O
evening	evening	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
humulog	humulog	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
carb	carb	NN	I-NP	O
controlled	controlled	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
was	be	VBD	B-VP	O
1.2	1.2	CD	B-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
Levoxyl	Levoxyl	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
FEN	FEN	NN	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
lytes	lyte	NNS	I-NP	O
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

--	--	:	O	O
GI	GI	NN	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
showed	show	VBD	B-VP	O
sludge	sludge	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
distended	distended	JJ	I-NP	O
CBD	CBD	NN	I-NP	O
.	.	.	O	O

Bili	Bili	NNP	B-NP	O
T	T	NN	I-NP	O
and	and	CC	I-NP	O
D	D	NN	I-NP	O
were	be	VBD	B-VP	O
added	add	VBN	I-VP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
abd	abd	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
tenderness	tenderness	NN	I-NP	O
so	so	IN	B-PP	O
her	her	PRP$	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
sludge	sludge	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
pathology	pathology	NN	I-NP	O
.	.	.	O	O

--	--	:	B-NP	O
ADDITIONAL	ADDITIONAL	JJ	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Monitor	Monitor	NNP	B-NP	O
your	your	PRP$	B-NP	O
BP	BP	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
if	if	IN	B-SBAR	O
>	>	SYM	B-NP	O
180	180	CD	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
Fingersticks	Fingerstick	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
before	before	IN	B-PP	O
each	each	DT	B-NP	O
meal	meal	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	I-NP	O
record	record	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
note	note	NN	I-NP	O
book	book	NN	I-NP	O
to	to	TO	B-VP	O
bring	bring	VB	I-VP	O
to	to	TO	B-PP	O
PCP	PCP	NN	B-NP	B-protein
appointment	appointment	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Return	Return	NN	B-NP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
extreme	extreme	JJ	B-NP	O
sweating	sweating	NN	I-NP	O
,	,	,	O	O
fainting	fainting	NN	B-NP	O
,	,	,	O	O
falling	fall	VBG	B-VP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerns	concern	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
UPEP/SPEP	UPEP/SPEP	NN	B-NP	O
.	.	.	O	O

Follow	Follow	NNP	B-NP	O
Blood	Blood	NNP	I-NP	O
Pressures	Pressures	NNP	I-NP	O
.	.	.	O	O

Follow	Follow	NNP	B-NP	O
Fingersticks	Fingersticks	NNP	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
OGARA	OGARA	NN	B-NP	B-protein
,	,	,	O	O
FLORENCIO	FLORENCIO	NN	B-NP	B-protein
,	,	,	O	O
PA-C	PA-C	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
IF08	IF08	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
9/12/06	9/12/06	CD	B-NP	O
@	@	SYM	I-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

